These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 27749102

  • 1. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
    Jiang H, Geng D, Liu H, Li Z, Cao J.
    Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C, Ge X, Wang L.
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [Abstract] [Full Text] [Related]

  • 4. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
    Zhang S, Lu C, Zhang X, Li J, Jiang H.
    Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
    [Abstract] [Full Text] [Related]

  • 5. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y, Pan L, Jiang M, Li D, Jin L.
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [Abstract] [Full Text] [Related]

  • 6. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L, Wang W, Rui Z, Zhou D.
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [Abstract] [Full Text] [Related]

  • 7. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M, Teng L, Wang Y, Zhang J, Sun X.
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [Abstract] [Full Text] [Related]

  • 8. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J, Wang Y, Zhang X, Liu S, Tian C, Wang H.
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [Abstract] [Full Text] [Related]

  • 9. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X.
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [Abstract] [Full Text] [Related]

  • 10. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M, Fan Y, Lv S, Xiao B, Ye M, Zhu X.
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [Abstract] [Full Text] [Related]

  • 11. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B.
    Drug Dev Ind Pharm; 2016 Oct; 42(5):694-700. PubMed ID: 26165247
    [Abstract] [Full Text] [Related]

  • 12. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J, Zhang L, Chen Z, Mao G, Gao Z, Lai X, Zhu X, Zhu J.
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [Abstract] [Full Text] [Related]

  • 13. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A.
    Curr Drug Deliv; 2019 Nov; 16(10):923-930. PubMed ID: 31663477
    [Abstract] [Full Text] [Related]

  • 14. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W, Song Y, Song W, Liu Y, Liu Z, Zhang D, Tang Z, Bai O.
    Sci Rep; 2020 May 12; 10(1):7832. PubMed ID: 32398729
    [Abstract] [Full Text] [Related]

  • 15. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H, Zhang N, Hao Y, Wang Y, Jia S, Zhang H, Zhang Y, Zhang Z.
    Drug Deliv; 2014 Aug 12; 21(5):379-87. PubMed ID: 24160816
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y, Zhao P, Wu S, Yang T, Chen Y, Zhang X, He C, Zheng C, Li K, Ma X, Xiang G.
    Int J Pharm; 2018 Jul 10; 545(1-2):261-273. PubMed ID: 29730175
    [Abstract] [Full Text] [Related]

  • 17. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB, Ko YT.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():419-426. PubMed ID: 25797481
    [Abstract] [Full Text] [Related]

  • 18. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T, Zhang S, Sun H.
    Oncol Rep; 2017 Feb 01; 37(2):1253-1260. PubMed ID: 28075466
    [Abstract] [Full Text] [Related]

  • 19. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice.
    Puglia C, Frasca G, Musumeci T, Rizza L, Puglisi G, Bonina F, Chiechio S.
    Eur J Pharm Biopharm; 2012 Jun 01; 81(2):288-93. PubMed ID: 22504443
    [Abstract] [Full Text] [Related]

  • 20. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F, Asghar S, Xu Y, Wang J, Jin X, Wang Z, Wang J, Ping Q, Zhou J, Xiao Y.
    Int J Pharm; 2016 Jun 15; 506(1-2):46-56. PubMed ID: 27094357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.